Jump Financial’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-168,597
Closed -$1.04M 2222
2025
Q4
$1.04M Buy
168,597
+6,989
+4% +$50.7K 0.01% 958
2025
Q3
$1.17M Buy
161,608
+151,017
+1,426% +$897K 0.01% 946
2025
Q2
$56.2K Sell
10,591
-123,745
-92% -$731K ﹤0.01% 1678
2025
Q1
$1.19M Buy
+134,336
New +$1.61M 0.02% 757
2024
Q4
Sell
-32,857
Closed -$900K 1874
2024
Q3
$900K Buy
+32,857
New +$889K 0.02% 842
2024
Q1
Sell
-19,047
Closed -$365K 2153
2023
Q4
$365K Sell
19,047
-65,877
-78% -$1.14M 0.01% 1228
2023
Q3
$1.36M Buy
84,924
+11,706
+16% +$223K 0.05% 526
2023
Q2
$1.7M Buy
+73,218
New +$1.6M 0.06% 453
2023
Q1
Sell
-46,029
Closed -$668K 1891
2022
Q4
$668K Buy
+46,029
New +$858K 0.04% 662

Other funds holding MYGN